ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 050

Predictive Value of the 2019 EULAR/ACR SLE Criteria’s Extra-Renal Domains to Renal Response One Year After Treatment in a Pediatric Lupus Nephritis Cohort

Sara Patrizi1, Megha Tandel2, Derek Boothroyd2 and Joyce Hsu1, 1Stanford Medicine, Children's Health, Palo Alto, CA, 2Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Lupus nephritis, patient outcomes, Pediatric rheumatology, pediatrics, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, March 30, 2023

Title: Posters: Clinical and Therapeutic I

Session Type: Poster Session A

Session Time: 6:00PM-7:00PM

Background/Purpose: In 2019, new classification criteria for SLE were developed by the EULAR/ACR. Prior research in adult lupus cohorts found a positive correlation between high summary score at diagnosis and SLE disease activity at 5 years, but it is unknown whether a higher summary score indicates more severe disease in a pediatric cohort. Using the new lupus criteria, this pediatric study evaluates the predictive value of higher summary scores and number of extra-renal domains at diagnosis to renal outcomes after treatment.

Methods: This is a retrospective, single center cohort study of all patients seen at Stanford Childrens Health diagnosed withSLEwith kidney involvement prior to their 18th birthday from 2010- 2022. For each patient, the EULAR/ACR summary score was calculated based on the clinical and laboratory criteria. Patients were dichotomized into two subgroups, those with low/moderate number (1-5) of extra-renal domains at diagnosis vs those with a high number (6-9). Patient baseline information was collected at diagnosis and follow up data was collected after 1 year. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) 2012 definition for renal response was utilized (no, partial [mild/moderate] or complete response) after 1 year of treatment as our outcome measure. Descriptive statistics were reported by group and an ordinal logistic regression was conducted to calculate adjusted odds ratio for renal response to determine if a higher summary score (30) and high number of extra-renal domains predicted poor renal response.

Results: Patient characteristics of our final cohort of 74 children are depicted in Table 1. Patients with a high number of extra-renal domains have 1.47 (95% CI: 0.55 – 2.91, p=0.44) times the odds of having a complete renal response than patients with a low/moderate number of domains (Table 2).

There were no statistically significant differences between the summary scores and the three renal response groups (Figure 1), although the no renal response group were comprised of more patients with a summary score30. Patients with a summary score 30 have 1.31 (95% CI: 0.50-3.44, p=0.59) times the odds of having a complete renal response than patients with a summary score 30 (Table 2).

Conclusion: In this study, we evaluated the predictive potential of the extra-renal domains and the summary score from the 2019 EULAR/ACR classification criteria in a pediatric cohort with SLE with renal involvement. We found that the number of extra-renal domains at diagnosis did not have a significant impact on renal response at one year. While there was no significant difference in the overall EULAR/ACR summary score at diagnosis and renal response after 1 year of treatment, patients with a summary score 30 had an increased trend toward having a complete renal response. This suggests that the overall summary score (a more quantitative, weighted score), rather than the number of domains, may predict renal outcomes in a pediatric lupus nephritis cohort. Future studies on larger cohorts are needed.

Supporting image 1Table 1. Patient Demographics, Clinical Characteristics and EULAR/ACR Classification Domains (N&#3f74)

Supporting image 2Figure 1. Overall Summary Score by Renal Response (N&#3f74)

Supporting image 3Table 2. Ordinal Logistic Regressions for Complete Renal Response (N&#3f74)


Disclosures: S. Patrizi: None; M. Tandel: None; D. Boothroyd: None; J. Hsu: None.

To cite this abstract in AMA style:

Patrizi S, Tandel M, Boothroyd D, Hsu J. Predictive Value of the 2019 EULAR/ACR SLE Criteria’s Extra-Renal Domains to Renal Response One Year After Treatment in a Pediatric Lupus Nephritis Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/predictive-value-of-the-2019-eular-acr-sle-criterias-extra-renal-domains-to-renal-response-one-year-after-treatment-in-a-pediatric-lupus-nephritis-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-value-of-the-2019-eular-acr-sle-criterias-extra-renal-domains-to-renal-response-one-year-after-treatment-in-a-pediatric-lupus-nephritis-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology